Tue 18'th Sep 2018
Clearside BioMedical, Inc Stock Analysis
Technical stock analysis for Tue 18'th Sep 2018
|Shorts||2.74% ( 2018-08-31 )|
Clearside BioMedical, Inc fell by -0.79% in the last day from $6.34 to $6.29 and has now fallen 4 days in a row. The price has fallen in 8 of the last 10 days and is down by -8.44% for this period. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -86 359 shares and in total 132 706 shares bought and sold for approximately $834 721.00.
Clearside BioMedical, Inc lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -44.43% during the next 3 months and, with 90% probability hold a price between $2.63 and $3.91 at the end of this period.
There are few to none technical positive signals at the moment. Clearside BioMedical, Inc holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $6.42 and $7.01. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Thursday September 13, 2018, which indicates further falls until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.
Relative Strength Index (RSI)
RSI14 is 43 and the stock is currently not being overbought or oversold
Support & Resistance
Clearside BioMedical, Inc finds support from accumulated volume at $6.28.
In general the stock tends to have controlled movements, but the low liquidity has increased the risk substantially.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
Very Low Low Medium High Very High
Clearside BioMedical, Inc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.Click for Top 5 Sell Candidates
|CLSD $6.29 $-0.05(-0.79%)|
CLSD is down $0.05 today, but where's it headed in October?
|Zacks Investment Research is releasing its prediction for CLSD based on the 1-3 month system that more than doubles the S&P 500.
Click here – the CLSD analysis is free »